Compounds > masoprocol

masoprocol and Amyotrophic Lateral Sclerosis

masoprocol has been researched along with Amyotrophic Lateral Sclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bogush, A; Boston-Howes, W; Pasinelli, P; Scolere, M; Trotti, D; Williams, EO1
Maragakis, NJ1

Other Studies

2 other study(ies) available for masoprocol and Amyotrophic Lateral Sclerosis

ArticleYear
Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: therapeutic implications for amyotrophic lateral sclerosis.
    Experimental neurology, 2008, Volume: 213, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Central Nervous System; Cyclooxygenase Inhibitors; Drug Resistance; Glutamic Acid; Humans; Masoprocol; Mice; Mice, Transgenic; Neurotoxins; Presynaptic Terminals; Superoxide Dismutase; Superoxide Dismutase-1; Synaptic Transmission; Treatment Failure; Up-Regulation

2008
Rethinking a drug treatment failure on a traditional ALS target.
    Experimental neurology, 2009, Volume: 216, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamic Acid; Humans; Masoprocol; Treatment Failure

2009